Satoko Sekimoto

Arylsulfatase A, a genetic modifier of Parkinson’s disease, is an α-synuclein chaperone

Jun Sung Lee, Kazuaki Kanai, Mari Suzuki et al. · Brain · 2019 · 68 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17

A Randomized Crossover Pilot Study of Telemedicine Delivered via iPads in Parkinson’s Disease

Satoko Sekimoto, Genko Oyama, Taku Hatano et al. · Parkinson s Disease · 2019 · 40 citations · Full text

Health Professions, Health Sciences, Neurology +17

Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury

Joshua K. Wong, Günther Deuschl, Robin Wolke et al. · Frontiers in Human Neuroscience · 2022 · 39 citations · Full text

Engineering, Neuroscience, Psychiatry +17

Closed-loop programming using external responses for deep brain stimulation in Parkinson's disease

Fuyuko Sasaki, Genko Oyama, Satoko Sekimoto et al. · Parkinsonism & Related Disorders · 2021 · 33 citations

Engineering, Biomedical Engineering, Neuroscience +16

Balance and Gait Improvements of Postoperative Rehabilitation in Patients with Parkinson’s Disease Treated with Subthalamic Nucleus Deep Brain Stimulation (STN-DBS)

Kazunori Sato, Noriaki Aita, Yoshihide Hokari et al. · Parkinson s Disease · 2019 · 16 citations · Full text

Medicine, Neurological Surgery, Neurosurgery +17